Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
33.74
-1.30 (-3.71%)
Mar 9, 2026, 1:29 PM EDT - Market open
Tyra Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 29.83 | 24.1 | 17.43 | 15.92 | 5.65 | |
| Research & Development | 102.93 | 80.08 | 62.52 | 43.01 | 20.64 | |
| Operating Expenses | 132.76 | 104.18 | 79.95 | 58.93 | 26.29 | |
| Operating Income | -132.76 | -104.18 | -79.95 | -58.93 | -26.29 | |
| Interest & Investment Income | 12.82 | 17.7 | 10.81 | 3.65 | 0.01 | |
| Other Non Operating Income (Expenses) | - | - | - | -0.05 | -0.02 | |
| Pretax Income | -119.95 | -86.48 | -69.13 | -55.33 | -26.29 | |
| Net Income | -119.95 | -86.48 | -69.13 | -55.33 | -26.29 | |
| Net Income to Common | -119.95 | -86.48 | -69.13 | -55.33 | -26.29 | |
| Shares Outstanding (Basic) | 60 | 57 | 43 | 42 | 14 | |
| Shares Outstanding (Diluted) | 60 | 57 | 43 | 42 | 14 | |
| Shares Change (YoY) | 4.17% | 33.98% | 1.96% | 203.94% | 793.58% | |
| EPS (Basic) | -2.01 | -1.51 | -1.62 | -1.32 | -1.91 | |
| EPS (Diluted) | -2.01 | -1.51 | -1.62 | -1.32 | -1.91 | |
| Free Cash Flow | -95.28 | -70.44 | -50.91 | -50.84 | -24.41 | |
| Free Cash Flow Per Share | -1.60 | -1.23 | -1.19 | -1.21 | -1.77 | |
| EBITDA | -132.22 | -103.66 | -79.59 | -58.63 | -26.15 | |
| D&A For EBITDA | 0.55 | 0.52 | 0.36 | 0.3 | 0.14 | |
| EBIT | -132.76 | -104.18 | -79.95 | -58.93 | -26.29 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.